Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.2%
Thu, 11 Jul 9:50

AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.2%Image source: DNY59/www.istockphoto.com

AMBALAL SARABHAI share price has zoomed 5% and is presently trading at Rs 74.2.

Meanwhile, the BSE HEALTHCARE index is at 38,514.7 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 2.1%) and ASTRAZENECA PHARMA (up 1.6%).

Glenmark Pharma (down 1.3%) and Sun Pharma (down 0.9%) are among the top losers today.

Over the last one year, AMBALAL SARABHAI has moved up from Rs 27.2 to Rs 74.2, registering a gain of Rs 47.0 (up 172.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,514.7, registering a gain of 48.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 104.9%), Cadila Healthcare (up 103.9%) and Lupin (up 101.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,947.1 .

The top gainers among the BSE Sensex today are Tata Motors (up 1.8%) and HCl Tech. (up 1.2%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,339.4 (up 0.1%). Tata Motors and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,947.1, registering a gain of 14,602.9 points (up 22.3%).

AMBALAL SARABHAI Financial Update...

AMBALAL SARABHAI net profit grew 131.5% YoY to Rs 101 million for the quarter ended March 2024, compared to a profit of Rs 44 million a year ago. Net sales rose 22.3% to Rs 543 million during the period as against Rs 444 million in January-March 2023.

For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.

The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 67.8.


Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.2%". Click here!